NCT00396357View on ClinicalTrials.gov

Efficacy/Safety of Vildagliptin and Metformin Combination Therapy in Patients With Type 2 Diabetes Not Well Controlled With Metformin Alone

PHASE3CompletedINTERVENTIONAL
Enrollment

914

Participants

Timeline

Start Date

October 31, 2006

Primary Completion Date

June 30, 2008

Conditions
Diabetes Mellitus, Type 2
Interventions
DRUG

Vildagliptin

DRUG

metformin

Trial Locations (2)

07936

Novartis Pharmaceuticals, East Hanover

Unknown

Novartis Investigative Site, Multiple Locations

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY